Search

Your search keyword '"Si-Qi Qiu"' showing total 36 results

Search Constraints

Start Over You searched for: Author "Si-Qi Qiu" Remove constraint Author: "Si-Qi Qiu"
36 results on '"Si-Qi Qiu"'

Search Results

1. EZH2 elicits CD8+ T-cell desert in esophageal squamous cell carcinoma via suppressing CXCL9 and dendritic cells

2. CD74 is a potential biomarker predicting the response to immune checkpoint blockade

Catalog

Books, media, physical & digital resources

3. Pan-cancer analysis reveals CCL5/CSF2 as potential predictive biomarkers for immune checkpoint inhibitors

4. Molecular and functional imaging in cancer-targeted therapy: current applications and future directions

5. Fluorescent image-guided surgery in breast cancer by intravenous application of a quenched fluorescence activity-based probe for cysteine cathepsins in a syngeneic mouse model

6. High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer

7. Markers Associated With Tumor Recurrence in Patients With Breast Cancer Achieving a Pathologic Complete Response After Neoadjuvant Chemotherapy

8. CXCL9 Is a Potential Biomarker of Immune Infiltration Associated With Favorable Prognosis in ER-Negative Breast Cancer

9. Implementation and benchmarking of a novel analytical framework to clinically evaluate tumor-specific fluorescent tracers

10. Over-Expressed Twist Associates with Markers of Epithelial Mesenchymal Transition and Predicts Poor Prognosis in Breast Cancers via ERK and Akt Activation.

11. Assessing the role of tumour-associated macrophage subsets in breast cancer subtypes using digital image analysis

13. Data from Autoantibody Signatures Combined with Epstein–Barr Virus Capsid Antigen-IgA as a Biomarker Panel for the Detection of Nasopharyngeal Carcinoma

14. Abstract PS6-53: Higher clinical lymph node stage predicts worse survival in patients with breast cancer who achieve a pathologic complete response after neoadjuvant chemotherapy

15. Consideration of breast cancer subtype in targeting the androgen receptor

16. Considering the biology of late recurrences in selecting patients for extended endocrine therapy in breast cancer

17. Validation and update of a lymph node metastasis prediction model for breast cancer

18. Implementation and benchmarking of a novel analytical framework to clinically evaluate tumor-specific fluorescent tracers

19. [Delineation of urban development boundary based on the combination of rigidity and elasti-city: A case of Yiwu City in Zhejiang Province, China.]

20. Androgen receptor expression inversely correlates with immune cell infiltration in human epidermal growth factor receptor 2-positive breast cancer

21. Micro-computed tomography (micro-CT) for intraoperative surgical margin assessment of breast cancer: A feasibility study in breast conserving surgery

22. Autoantibody Signatures Combined with Epstein–Barr Virus Capsid Antigen-IgA as a Biomarker Panel for the Detection of Nasopharyngeal Carcinoma

23. ERα inhibits epithelial-mesenchymal transition by suppressing Bmi1 in breast cancer

25. Evolution in sentinel lymph node biopsy in breast cancer

26. Breast reconstruction with single-pedicle TRAM flap in breast cancer patients with low midline abdominal scar

27. A nomogram to predict the probability of axillary lymph node metastasis in early breast cancer patients with positive axillary ultrasound

28. Over-Expressed Twist Associates with Markers of Epithelial Mesenchymal Transition and Predicts Poor Prognosis in Breast Cancers via ERK and Akt Activation

29. Clinicopathological features and prognostic factors of young breast cancers in Eastern Guangdong of China

30. Combination of autoantibodies against NY-ESO-1 and viral capsid antigen immunoglobulin A for improved detection of nasopharyngeal carcinoma

31. Diagnostic and therapeutic strategy and the most efficient prognostic factors of breast malignant fibrous histiocytoma

32. Abstract P4-01-01: Phase II in-human dose escalation study of the optical molecular imaging tracer bevacizumab-800cw for molecular fluorescence guided surgery in primary breast cancer patients

33. Combination of autoantibodies against NY-ESO-1 and viral capsid antigen immunoglobulin A for improved detection of nasopharyngeal carcinoma.

34. Diagnostic and therapeutic strategy and the most efficient prognostic factors of breast malignant fibrous histiocytoma.